Tirzepatide weight loss timelines show even greater reductions
Sang, J., Tang, R., Yang, M
It's not uncommon for people to notice a difference in their energy levels or metabolism within the first few weeks of this initial phase
GLP-1s Show Promise for Mental Health Beyond weight loss, emerging research suggests GLP-1 receptor agonists might have direct mental health benefits: Reduced binge-eating and food cravings in patients with BED and obesity Lower rates of substance use in preliminary studies (reduced alcohol and nicotine cravings) Improved mood and quality-of-life scores independent of weight loss No increase in depression or suicidality (the FDA and EMA both reviewed this and found no causal link) In fact, large trials like the STEP studies showed slightly lower rates of depressive symptoms in GLP-1-treated groups compared to placebo
FDA-approved GLP-1 receptor agonists include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda)
Genetic mechanisms of abiotic stress tolerance that translate to crop yield stability